Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclosporine with Daunorubicin and Cytarabine for Older AML
NCT00066794Phase 2Completed
- Sponsor
- SWOG Cancer Research Network
- Start
- Jul 2004
- Primary completion
- Feb 2007
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of cyclosporine in acute myeloid leukemia (AML), sponsored by SWOG Cancer Research Network. Primary endpoint: Complete Remission. Started Jul 2004; status: completed.
02
Drugs
cyclosporine
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT00066794.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00066794.